A Genetic Test to Identify People at High Risk of Heart Failure

Xintian Ge1,2, Bek Brittain1, Luke Dawson3

  • 1Centre for Diabetes Research, Harry Perkins Institute of Medical Research, Nedlands, WA 6009, Australia.

Insights

A new genetic test can identify individuals at high risk for heart failure (HF) before clinical signs appear. This breakthrough offers potential for earlier intervention and improved patient outcomes in cardiovascular disease management.

Area of Science:

  • Cardiovascular Genetics
  • Genomic Prediction
  • Biomarker Discovery

Background:

  • Heart failure (HF) is a significant global health burden.
  • Current methods lack the ability to predict HF risk accurately before clinical manifestation.
  • Early intervention strategies are crucial for managing and potentially preventing HF progression.

Purpose of the Study:

  • To develop and validate a novel genetic test for predicting heart failure (HF) risk.
  • To identify genetic variants associated with HF development.
  • To assess the clinical utility of a comprehensive genetic risk prediction tool.

Main Methods:

  • Genome-wide interaction and association analyses were performed on the Baker Biobank cohort.
  • A two-phase genetic test was developed, identifying 41 and 29 genetic variants respectively.
  • The aggregate test was validated across three independent cohorts: Baker Biobank, Busselton Health Study, and Atherosclerosis Risk in Communities.

Main Results:

  • The aggregate genetic test demonstrated high predictive accuracy with an Area Under the Curve (AUC) of 0.93 and balanced accuracy of 0.89 in the development cohort.
  • High genetic risk individuals in the Baker Biobank cohort showed a significantly elevated odds ratio (533.2) for HF.
  • Validation in independent cohorts yielded AUCs of 0.83 and 0.72, with corresponding odds ratios of 12.3 and 4.6, confirming test robustness.

Conclusions:

  • Genetic factors play a critical role in the pathogenesis of heart failure.
  • The developed genetic test is a robust and accurate tool for predicting HF risk.
  • This test holds significant potential for early clinical risk stratification and personalized HF prevention strategies.

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
12.3K
Exercise Stress Test01:26

Exercise Stress Test

Introduction
Exercise stress testing, commonly known as a treadmill test, is a noninvasive procedure used to evaluate cardiovascular function and diagnose heart conditions.
Definition
An exercise stress test measures the heart's response to exertion using a treadmill or stationary bicycle. Chest electrodes record the heart's electrical activity through an ECG, and blood pressure is monitored regularly.
Purposes
151
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
41
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Human Genetics01:28

Human Genetics

Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
516
Genetic Screens02:46

Genetic Screens

Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
4.8K